Cytokinetics, Incorporated (CYTK) Net margin 2016–2025
Cytokinetics, Incorporated (CYTK) net profit margin by fiscal year — reported net income divided by reported revenue.
-891.6%FY2025 · since FY2016: 15.5% → -891.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -891.6% | +2299.5 pp |
| FY2024 | -3191.1% | +3797.5 pp |
| FY2023 | -6988.6% | -6577.4 pp |
| FY2022 | -411.2% | -105.5 pp |
| FY2021 | -305.7% | -77.7 pp |
| FY2020 | -228.0% | +224.9 pp |
| FY2019 | -452.9% | -115.5 pp |
| FY2018 | -337.4% | +618.5 pp |
| FY2017 | -955.9% | -971.4 pp |
| FY2016 | 15.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice